HIGHLIGHTS
- who: Alexey Sokolov et al. from the (UNIVERSITY) have published the article: Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells, in the Journal: Viruses 2022, 14, 317. of /2022/
- what: The authors report preliminary results of inhibiting SARS-CoV-2 in_vitro replication by the treatment of the target cells by ferristatin II, a small-size molecule that can selectively degrade transferrin receptor 1.
- how: For evaluation of ferristatin virus neutralization capacity the authors used a modified microneutralization assay.
- future: The authors hypothesize that blocks the TfR1-mediated SARS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.